The data suggested that TFAP2A positively regulated “GPCR LIGAND BINDING” signaling pathways in Adrenocortical carcinoma (ACC), COAD, Lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), OV, and THCA. This evidence concerns the gene TFAP2A and colon adenocarcinoma.